A citation-based method for searching scientific literature

N Müller, M J Schwarz, S Dehning, A Douhe, A Cerovecki, B Goldstein-Müller, I Spellmann, G Hetzel, K Maino, N Kleindienst, H-J Möller, V Arolt, M Riedel. Mol Psychiatry 2006
Times Cited: 511







List of co-cited articles
1400 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


The expression of genes encoding for COX-2, MPO, iNOS, and sPLA2-IIA in patients with recurrent depressive disorder.
Piotr Gałecki, Elżbieta Gałecka, Michael Maes, Marcelina Chamielec, Agata Orzechowska, Kinga Bobińska, Andrzej Lewiński, Janusz Szemraj. J Affect Disord 2012
81
9

Depressive disorders and immunity: 20 years of progress and discovery.
Michael R Irwin, Andrew H Miller. Brain Behav Immun 2007
410
8

Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice.
Madhukar H Trivedi, A John Rush, Stephen R Wisniewski, Andrew A Nierenberg, Diane Warden, Louise Ritz, Grayson Norquist, Robert H Howland, Barry Lebowitz, Patrick J McGrath,[...]. Am J Psychiatry 2006
8

Cytokines and major depression.
Olga J G Schiepers, Marieke C Wichers, Michael Maes. Prog Neuropsychopharmacol Biol Psychiatry 2005
775
8

Antidepressant treatment resistance is associated with increased inflammatory markers in patients with major depressive disorder.
Ebrahim Haroon, Alexander W Daguanno, Bobbi J Woolwine, David R Goldsmith, Wendy M Baer, Evanthia C Wommack, Jennifer C Felger, Andrew H Miller. Psychoneuroendocrinology 2018
88
9

Individual differences in the peripheral immune system promote resilience versus susceptibility to social stress.
Georgia E Hodes, Madeline L Pfau, Marylene Leboeuf, Sam A Golden, Daniel J Christoffel, Dana Bregman, Nicole Rebusi, Mitra Heshmati, Hossein Aleyasin, Brandon L Warren,[...]. Proc Natl Acad Sci U S A 2014
343
7

Associations of C-reactive protein and interleukin-6 with cognitive symptoms of depression: 12-year follow-up of the Whitehall II study.
D Gimeno, M Kivimäki, E J Brunner, M Elovainio, R De Vogli, A Steptoe, M Kumari, G D O Lowe, A Rumley, M G Marmot,[...]. Psychol Med 2009
338
7

Higher plasma interleukin-6 (IL-6) level is associated with SSRI- or SNRI-refractory depression.
Reiji Yoshimura, Hikaru Hori, Atsuko Ikenouchi-Sugita, Wakako Umene-Nakano, Nobuhisa Ueda, Jun Nakamura. Prog Neuropsychopharmacol Biol Psychiatry 2009
131
7



Lack of clinical therapeutic benefit of antidepressants is associated overall activation of the inflammatory system.
L A Carvalho, J P Torre, A S Papadopoulos, L Poon, M F Juruena, K Markopoulou, A J Cleare, C M Pariante. J Affect Disord 2013
101
7



Raised plasma levels of tumor necrosis factor alpha in patients with depression: normalization during electroconvulsive therapy.
Knut A Hestad, Sverre Tønseth, Charlotte D Støen, Thor Ueland, Pål Aukrust. J ECT 2003
160
7


Integrating neuroimmune systems in the neurobiology of depression.
Eric S Wohleb, Tina Franklin, Masaaki Iwata, Ronald S Duman. Nat Rev Neurosci 2016
256
7

Depression as a microglial disease.
Raz Yirmiya, Neta Rimmerman, Ronen Reshef. Trends Neurosci 2015
343
7

Minocycline as adjunctive therapy for patients with unipolar psychotic depression: an open-label study.
Tsuyoshi Miyaoka, Rei Wake, Motohide Furuya, Kristian Liaury, Masa Ieda, Kazunori Kawakami, Keiko Tsuchie, Michiyo Taki, Kotomi Ishihara, Tomoko Araki,[...]. Prog Neuropsychopharmacol Biol Psychiatry 2012
136
7

Major depressive disorder.
Christian Otte, Stefan M Gold, Brenda W Penninx, Carmine M Pariante, Amit Etkin, Maurizio Fava, David C Mohr, Alan F Schatzberg. Nat Rev Dis Primers 2016
447
7

Therapeutic effects of minocycline on mild-to-moderate depression in HIV patients: a double-blind, placebo-controlled, randomized trial.
Hamid Emadi-Kouchak, Payam Mohammadinejad, Ali Asadollahi-Amin, Mehrnaz Rasoulinejad, Atefeh Zeinoddini, Alireza Yalda, Shahin Akhondzadeh. Int Clin Psychopharmacol 2016
41
17


Pioglitazone adjunctive therapy for moderate-to-severe major depressive disorder: randomized double-blind placebo-controlled trial.
Khatereh Sepanjnia, Amirhossein Modabbernia, Mandana Ashrafi, Mohammad-Jafar Modabbernia, Shahin Akhondzadeh. Neuropsychopharmacology 2012
87
8

Cytokine production and treatment response in major depressive disorder.
S Lanquillon, J C Krieg, U Bening-Abu-Shach, H Vedder. Neuropsychopharmacology 2000
502
7

Effectiveness and tolerance of anti-inflammatory drugs' add-on therapy in major mental disorders: a systematic qualitative review.
G Fond, N Hamdani, F Kapczinski, W Boukouaci, N Drancourt, A Dargel, J Oliveira, E Le Guen, E Marlinge, R Tamouza,[...]. Acta Psychiatr Scand 2014
105
7

Inflammation as a predictive biomarker for response to omega-3 fatty acids in major depressive disorder: a proof-of-concept study.
M H Rapaport, A A Nierenberg, P J Schettler, B Kinkead, A Cardoos, R Walker, D Mischoulon. Mol Psychiatry 2016
147
7

CRP, IL-6 and depression: a systematic review and meta-analysis of longitudinal studies.
Vyara Valkanova, Klaus P Ebmeier, Charlotte L Allan. J Affect Disord 2013
475
7

Childhood maltreatment predicts adult inflammation in a life-course study.
Andrea Danese, Carmine M Pariante, Avshalom Caspi, Alan Taylor, Richie Poulton. Proc Natl Acad Sci U S A 2007
674
7

Kynurenine pathway in major depression: evidence of impaired neuroprotection.
Aye-Mu Myint, Yong Ku Kim, Robert Verkerk, Simon Scharpé, Harry Steinbusch, Brian Leonard. J Affect Disord 2007
356
7


Inflammation-associated depression: from serotonin to kynurenine.
Robert Dantzer, Jason C O'Connor, Marcus A Lawson, Keith W Kelley. Psychoneuroendocrinology 2011
437
7

Functional biomarkers of depression: diagnosis, treatment, and pathophysiology.
Heath D Schmidt, Richard C Shelton, Ronald S Duman. Neuropsychopharmacology 2011
266
7

Treatment-resistant depression and peripheral C-reactive protein.
Samuel R Chamberlain, Jonathan Cavanagh, Peter de Boer, Valeria Mondelli, Declan N C Jones, Wayne C Drevets, Philip J Cowen, Neil A Harrison, Linda Pointon, Carmine M Pariante,[...]. Br J Psychiatry 2019
103
7

What does plasma CRP tell us about peripheral and central inflammation in depression?
Jennifer C Felger, Ebrahim Haroon, Trusharth A Patel, David R Goldsmith, Evanthia C Wommack, Bobbi J Woolwine, Ngoc-Anh Le, Rachel Feinberg, Malu G Tansey, Andrew H Miller. Mol Psychiatry 2020
95
7

Anti-inflammatory treatment for major depressive disorder: implications for patients with an elevated immune profile and non-responders to standard antidepressant therapy.
Paula Kopschina Feltes, Janine Doorduin, Hans C Klein, Luis Eduardo Juárez-Orozco, Rudi Ajo Dierckx, Cristina M Moriguchi-Jeckel, Erik Fj de Vries. J Psychopharmacol 2017
89
7

Inhibition of neuronal nitric oxide synthase in the rat hippocampus induces antidepressant-like effects.
Sâmia Regiane Lourenço Joca, Francisco Silveira Guimarães. Psychopharmacology (Berl) 2006
145
6

Inflammation causes mood changes through alterations in subgenual cingulate activity and mesolimbic connectivity.
Neil A Harrison, Lena Brydon, Cicely Walker, Marcus A Gray, Andrew Steptoe, Hugo D Critchley. Biol Psychiatry 2009
432
6


Brain interleukin-1 mediates chronic stress-induced depression in mice via adrenocortical activation and hippocampal neurogenesis suppression.
I Goshen, T Kreisel, O Ben-Menachem-Zidon, T Licht, J Weidenfeld, T Ben-Hur, R Yirmiya. Mol Psychiatry 2008
494
6

Celecoxib enhances the effect of reboxetine and fluoxetine on cortical noradrenaline and serotonin output in the rat.
Daniella Johansson, Aki Falk, Monica M Marcus, Torgny H Svensson. Prog Neuropsychopharmacol Biol Psychiatry 2012
38
15

Negative immunoregulatory effects of antidepressants: inhibition of interferon-gamma and stimulation of interleukin-10 secretion.
M Maes, C Song, A H Lin, S Bonaccorso, G Kenis, R De Jongh, E Bosmans, S Scharpé. Neuropsychopharmacology 1999
272
6

Immunological aspects in the neurobiology of suicide: elevated microglial density in schizophrenia and depression is associated with suicide.
Johann Steiner, Hendrik Bielau, Ralf Brisch, Peter Danos, Oliver Ullrich, Christian Mawrin, Hans-Gert Bernstein, Bernhard Bogerts. J Psychiatr Res 2008
478
6

Inflammation, Glutamate, and Glia: A Trio of Trouble in Mood Disorders.
Ebrahim Haroon, Andrew H Miller, Gerard Sanacora. Neuropsychopharmacology 2017
149
6

Candidate genes expression profile associated with antidepressants response in the GENDEP study: differentiating between baseline 'predictors' and longitudinal 'targets'.
Annamaria Cattaneo, Massimo Gennarelli, Rudolf Uher, Gerome Breen, Anne Farmer, Katherine J Aitchison, Ian W Craig, Christoph Anacker, Patricia A Zunsztain, Peter McGuffin,[...]. Neuropsychopharmacology 2013
268
6

Novel therapeutic targets in depression: minocycline as a candidate treatment.
Joanna K Soczynska, Rodrigo B Mansur, Elisa Brietzke, Walter Swardfager, Sidney H Kennedy, Hanna O Woldeyohannes, Alissa M Powell, Marena S Manierka, Roger S McIntyre. Behav Brain Res 2012
110
6

High Kynurenine (a Tryptophan Metabolite) Predicts Remission in Patients with Major Depression to Add-on Treatment with Celecoxib.
Daniela Krause, Aye-Mu Myint, Christine Schuett, Richard Musil, Sandra Dehning, Anja Cerovecki, Michael Riedel, Volker Arolt, Markus J Schwarz, Norbert Müller. Front Psychiatry 2017
19
31

Interleukin-1 receptor activation by systemic lipopolysaccharide induces behavioral despair linked to MAPK regulation of CNS serotonin transporters.
Chong-Bin Zhu, Kathryn M Lindler, Anthony W Owens, Lynette C Daws, Randy D Blakely, William A Hewlett. Neuropsychopharmacology 2010
184
6

Activation of central nervous system inflammatory pathways by interferon-alpha: relationship to monoamines and depression.
Charles L Raison, Andrey S Borisov, Matthias Majer, Daniel F Drake, Giuseppe Pagnoni, Bobbi J Woolwine, Gerald J Vogt, Breanne Massung, Andrew H Miller. Biol Psychiatry 2009
237
6

Cytokine targets in the brain: impact on neurotransmitters and neurocircuits.
Andrew H Miller, Ebrahim Haroon, Charles L Raison, Jennifer C Felger. Depress Anxiety 2013
369
6

Dopaminergic mechanisms of reduced basal ganglia responses to hedonic reward during interferon alfa administration.
Lucile Capuron, Giuseppe Pagnoni, Daniel F Drake, Bobbi J Woolwine, James R Spivey, Ronald J Crowe, John R Votaw, Mark M Goodman, Andrew H Miller. Arch Gen Psychiatry 2012
214
6

The impact of major depressive disorder on the short- and long-term outcome of Crohn's disease treatment with infliximab.
P Persoons, S Vermeire, K Demyttenaere, B Fischler, J Vandenberghe, L Van Oudenhove, M Pierik, T Hlavaty, G Van Assche, M Noman,[...]. Aliment Pharmacol Ther 2005
153
6


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.